Literature DB >> 1384916

Effects of nitric oxide synthase inhibitors, L-NG-nitroarginine and L-NG-nitroarginine methyl ester, on responses to vasodilators of the guinea-pig coronary vasculature.

A Vials1, G Burnstock.   

Abstract

1. The effects of L-NG-nitroarginine (L-NOARG) and L-NG-nitroarginine methyl ester (L-NAME) on vasodilatation induced by ATP, substance P, 5-hydroxytryptamine (5-HT), bradykinin and sodium nitroprusside (SNP) were examined in the guinea-pig coronary bed, by use of a Langendorff technique. The effects of these inhibitors of nitric oxide synthesis were assessed on their ability to inhibit both the amplitude and the area of the vasodilator response. 2. The vasodilator responses evoked by low doses of 5-HT (5 x 10(-10)-10(-8) mol) were almost abolished by L-NAME and L-NOARG (both at 10(-5), 3 x 10(-5) and 10(-4) M), although L-NOARG (3 x 10(-5) M) was significantly less potent than L-NAME (3 x 10(-5) M) as an inhibitor of vasodilator responses to 5-HT (5 x 10(-8) mol). 3. The vasodilator responses evoked by substance P (5 x 10(-12)-5 x 10(-9) mol) were reduced in the presence of L-NAME and L-NOARG (both at 10(-5) and 3 x 10(-5) M). The response to substance P was almost abolished by L-NAME and L-NOARG (both at 10(-4) M). 4. The amplitude of the vasodilator responses to ATP (5 x 10(-11) and 5 x 10(-9)-5 x 10(-7) mol) was little affected by either L-NAME or L-NOARG (both at 10(-5), 3 x 10(-5) and 10(-4) M).7. It is concluded that in the guinea-pig coronary vasculature, the vasodilatation evoked by substance P and low doses of 5-HT is mediated almost exclusively via nitric oxide, whereas the vasodilatations evoked by ATP and bradykinin appear to involve other mechanisms in addition to the release of nitric oxide. L-NAME was a more effective agent than L-NOARG in inhibiting the vasodilator actions of 5-HT and ATP in this preparation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384916      PMCID: PMC1907844          DOI: 10.1111/j.1476-5381.1992.tb12790.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

Review 1.  The role of endothelium in the responses of vascular smooth muscle to drugs.

Authors:  R F Furchgott
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

Review 2.  Role of endothelium in responses of vascular smooth muscle.

Authors:  R F Furchgott
Journal:  Circ Res       Date:  1983-11       Impact factor: 17.367

3.  Arginine is a physiological precursor of endothelium-derived nitric oxide.

Authors:  H H Schmidt; H Nau; W Wittfoht; J Gerlach; K E Prescher; M M Klein; F Niroomand; E Böhme
Journal:  Eur J Pharmacol       Date:  1988-09-13       Impact factor: 4.432

4.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

5.  ATP mediates coronary vasoconstriction via P2x-purinoceptors and coronary vasodilatation via P2y-purinoceptors in the isolated perfused rat heart.

Authors:  A M Hopwood; G Burnstock
Journal:  Eur J Pharmacol       Date:  1987-04-07       Impact factor: 4.432

6.  5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.

Authors:  R A Cohen; J T Shepherd; P M Vanhoutte
Journal:  Am J Physiol       Date:  1983-12

7.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

8.  A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.

Authors:  D D Rees; R M Palmer; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

9.  Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.

Authors:  L J Ignarro; R E Byrns; G M Buga; K S Wood
Journal:  Circ Res       Date:  1987-12       Impact factor: 17.367

10.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

Authors:  R M Palmer; D D Rees; D S Ashton; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

View more
  6 in total

1.  Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia.

Authors:  R G Bogle; P G McLean; A Ahluwalia; P Vallance
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Effects of pyrimidines on the guinea-pig coronary vasculature.

Authors:  A J Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.

Authors:  A Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

4.  Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea.

Authors:  V Schlemper; J B Calixto
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

5.  Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway.

Authors:  Kim Vriens; Phalguni Tewari Kumar; Caroline Struyfs; Tanne L Cools; Pieter Spincemaille; Tadej Kokalj; Belém Sampaio-Marques; Paula Ludovico; Jeroen Lammertyn; Bruno P A Cammue; Karin Thevissen
Journal:  Oxid Med Cell Longev       Date:  2017-10-10       Impact factor: 6.543

Review 6.  Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges.

Authors:  Jan Víteček; Antonín Lojek; Giuseppe Valacchi; Lukáš Kubala
Journal:  Mediators Inflamm       Date:  2012-09-04       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.